Related by context. All words. (Click for frequent words.) 70 cognitive deficits 67 cognitive impairment 66 neurocognitive deficits 65 metabolic abnormalities 64 parkinsonism 64 neuronal dysfunction 64 extrapyramidal symptoms 63 impaired cognition 63 poststroke 62 autonomic dysfunction 62 bronchopulmonary dysplasia 62 dopaminergic therapy 62 thyroid dysfunction 62 idiopathic Parkinson disease 62 proliferative diabetic retinopathy 62 progressive neurodegenerative disorder 62 tau pathology 62 subclinical 61 neurologic disorders 61 hyperinsulinemia 61 PAOD 61 neurodegeneration 61 cardiac dysfunction 61 myeloproliferative diseases 61 cognitive function 61 neuropsychological deficits 61 juvenile idiopathic arthritis JIA 60 neurologic 60 myoclonus 60 poststroke depression 60 generalized seizures 60 subclinical atherosclerosis 60 neurologic symptoms 60 comorbid anxiety 60 amyloid pathology 60 T1DM 60 alexithymia 60 metabolic acidosis 60 AAT deficiency 60 Alzheimer Disease AD 60 nonalcoholic steatohepatitis 60 postoperative delirium 60 chronic pancreatitis 60 CTEPH 60 euthymic patients 60 Hashimoto thyroiditis 60 somatic symptoms 60 Parkinson disease PD 59 cerebral infarction 59 systolic hypertension 59 proliferative retinopathy 59 myocardial ischemia 59 neuropathies 59 carotid atherosclerosis 59 cerebral ischemia 59 Cognitive impairment 59 neuropsychiatric disorders 59 hippocampal atrophy 59 rheumatic disease 59 GH deficiency 59 bladder dysfunction 59 neuropsychiatric symptoms 59 cognitive impairments 59 subclinical hypothyroidism 59 neuromotor 59 cytopenias 59 axonal damage 59 neuroprotective effects 59 adrenal insufficiency 59 comorbid disorders 59 depressive symptomatology 59 psychosocial functioning 59 extrapyramidal 59 behavioral abnormalities 59 macrovascular complications 59 renal fibrosis 59 atherosclerotic disease 59 pulmonary hypertension PH 59 choroidal neovascularization 59 coagulopathy 59 cognitive functioning 58 white matter hyperintensities 58 microalbuminuria 58 Mild cognitive impairment 58 neuropsychological impairments 58 underlying pathophysiology 58 predisposing factor 58 Alzheimers disease 58 pathophysiologic 58 T2DM 58 neurodevelopmental 58 neuropsychiatric disorder 58 alkalosis 58 hyperglycaemia 58 juvenile idiopathic arthritis 58 brain lesions 58 hyperprolactinemia 58 pathophysiological mechanisms 58 motor neuron degeneration 58 Sleep disordered breathing 58 synaptic function 58 diabetic gastroparesis 58 parkinsonian symptoms 58 neurocognitive 58 cognition 58 microvascular complications 58 extrapyramidal symptoms EPS 58 geographic atrophy 58 artery stenosis 58 postoperative AF 58 subsyndromal 58 intracranial hypertension 58 gastrointestinal dysfunction 58 neurological abnormalities 58 coronary artery atherosclerosis 58 Korsakoff syndrome 58 nerve degeneration 58 hepatic steatosis 58 neurocognitive impairment 58 Neovascular AMD 58 Wernicke Korsakoff syndrome 58 myeloproliferative neoplasms 58 neurodevelopmental outcomes 58 dysthymic disorder 58 hepatic fibrosis 58 mood dysregulation 58 neurodegenerative disorder 58 neurological manifestations 58 microvascular disease 58 hyperreflexia 58 hemiparesis 58 neurologic disorder 58 cognitive decline 58 mood disorders 58 epilepsy 58 neuropathological 58 prolactin levels 58 intermittent claudication 58 Diabetic neuropathy 58 psychiatric comorbidity 58 delayed gastric emptying 58 neurologic dysfunction 58 hyperparathyroidism 58 Parkinsonian 58 von Willebrand disease 57 recurrent abdominal pain 57 endothelial dysfunction 57 behavioral disturbances 57 cardiac hypertrophy 57 mild cognitive 57 mitochondrial dysfunction 57 neovascular 57 overactive bladder symptoms 57 cortical blindness 57 xerostomia 57 intraventricular hemorrhage 57 prefrontal cortical 57 diabetic kidney 57 akinesia 57 psychiatric disorders 57 cerebellar 57 hypometabolism 57 neuropsychiatric diseases 57 Obstructive sleep apnea 57 neurological impairment 57 FTLD 57 cerebral vasospasm 57 Pulmonary hypertension 57 Alzheimer pathology 57 degenerative disorders 57 SRBD 57 neuropsychological functioning 57 hypogonadotropic hypogonadism 57 airway reactivity 57 dissociative disorders 57 Relapsing remitting 57 neurocognitive function 57 interstitial cystitis 57 bullous 57 lung fibrosis 57 LUTS 57 demyelination 57 amyloid deposition 57 subclinical hyperthyroidism 57 generalized epilepsy 57 neurodevelopmental outcome 57 Excessive daytime sleepiness 57 induce orthostatic hypotension 57 gastric carcinoma 57 comorbid depression 57 Chronic insomnia 57 metabolic disturbances 57 neurologic impairment 57 arterial thickening 57 persistent pulmonary hypertension 57 arterial calcification 57 cognitive dysfunctions 57 degenerative neurological diseases 57 nerve palsy 57 non alcoholic steatohepatitis 57 Parkinsonian Syndromes 57 diabetic nephropathy 57 adrenal function 57 tic disorders 57 onset diabetes mellitus 57 LHON 57 multi infarct dementia 57 Frontal lobe 57 obstructive sleep apnea 57 autoimmune thyroiditis 57 renal disease 57 neurodevelopmental disorder 57 obesity insulin resistance 57 mental retardation epilepsy 57 hypoxemia 57 olfactory dysfunction 57 lymphangioleiomyomatosis LAM 57 subcortical 57 diabetes mellitus DM 57 renal dysfunction 57 chronic thromboembolic pulmonary 57 OSAHS 57 nonalcoholic steatohepatitis NASH 57 Major Depressive Disorder MDD 57 fibrotic disease 57 primary generalized tonic 57 APOE e4 57 lichen planus 56 neurodegenerative disease 56 retinitis pigmentosa RP 56 neurogenic 56 Aortic stenosis 56 leukemia AML 56 aMCI precursor 56 interstitial nephritis 56 neuropathic pain 56 Sjögren syndrome 56 neurotoxicity 56 disc degeneration 56 variceal bleeding 56 optic neuropathy 56 hereditary predisposition 56 hippocampal volume 56 CP CPPS 56 glucose intolerance 56 Parkinsons disease 56 systemic inflammation 56 POAG 56 airway hyperresponsiveness 56 hyperalgesia 56 decompensated heart failure 56 fibromyalgia syndrome 56 NF2 56 renal insufficiency 56 pheochromocytoma 56 parkinsonian 56 tardive dyskinesia TD 56 cardiac fibrosis 56 cerebrovascular accident 56 chorea 56 alcoholic fatty liver 56 dietary interventions 56 neural degeneration 56 Critical limb ischemia 56 arterial hypertension 56 NAFLD 56 cachexia 56 Bronchiectasis 56 Severe Primary IGFD 56 neurological dysfunction 56 psychiatric comorbidities 56 pyloric stenosis 56 paralysis blindness 56 neuropathologic 56 subchronic 56 knee osteoarthritis OA 56 anticholinergic effects 56 epilepsies 56 familial adenomatous polyposis 56 diabetic retinopathy DR 56 lipid abnormalities 56 Lennox Gastaut syndrome 56 systemic lupus erythematosus 56 cortical excitability 56 perioperative complications 56 compensatory mechanisms 56 occlusion CRVO 56 prostate carcinogenesis 56 schizophrenia CIAS 56 hyperphenylalaninemia HPA due 56 ventricular remodeling 56 Orthostatic hypotension 56 gastro oesophageal reflux 56 affective psychosis 56 neurologic sequelae 56 Vitamin D insufficiency 56 SNHL 56 HeFH 56 sporadic ALS 56 cognitive functions 56 left ventricular dysfunction 56 macrovascular disease 56 sensory disturbances 56 syndrome OSAS 56 post thrombotic syndrome 56 myositis 56 cortisol secretion 56 tic disorder 56 leukoencephalopathy 56 Pervasive Developmental Disorder 56 reflux symptoms 56 hypercalcemia 56 thyrotoxicosis 56 renal scarring 56 antioxidant supplementation 56 Cushing syndrome 56 hypothalamic pituitary adrenal axis 56 rheumatoid arthritis osteoarthritis ankylosing 56 remyelination 56 Leber Congenital Amaurosis LCA 56 optic neuritis 56 uncontrolled epilepsy 56 albuminuria 56 insulin resistance 56 untreated celiac disease 56 mixed hyperlipidemia 56 neuroinflammation 56 myocardial fibrosis 56 Erythropoietic therapies may 56 Depressive symptoms 56 exploratory endpoints 56 colorectal adenoma 56 IBS C 56 hypochondriasis 56 Vitamin B# deficiency 56 neovascular AMD 56 nondemented 56 androgen deprivation 56 dysarthria 56 neurologic deficits 56 Parkinsonism 56 gastrointestinal motility 55 primidone 55 pancytopenia 55 chronic renal insufficiency 55 syringomyelia 55 pharmacological therapies 55 Major Depressive Disorder 55 activated microglia 55 neurological degeneration 55 vasospasm 55 etiologies 55 hemiplegia 55 neurodevelopment 55 autoimmune thyroid 55 brain atrophy 55 insulin resistance syndrome 55 hydrops 55 retinopathy 55 ADPKD 55 idiopathic thrombocytopenic purpura 55 diabetic microvascular complications 55 NF1 55 macroalbuminuria 55 affective psychoses 55 hepatotoxicity 55 Genetic predisposition 55 metabolic abnormality 55 fibrosis 55 adrenal suppression 55 neurosensory 55 androgen excess 55 endotoxemia 55 myeloproliferative disorders 55 malignant transformation 55 monoclonal gammopathy 55 overt nephropathy 55 EoE 55 atherosclerosis 55 acetabular dysplasia 55 carotid stenosis 55 elevated triglyceride levels 55 neurotoxic effects 55 childhood disintegrative disorder 55 progranulin mutations 55 anatomical abnormalities 55 pharmacologic treatments 55 sequelae 55 paraneoplastic 55 Magnesium deficiency 55 diabetes mellitus 55 neuroimaging studies 55 lysosomal storage disease 55 nasal obstruction 55 vascular cognitive impairment 55 neurologic diseases 55 mitochondrial toxicity 55 neurodevelopmental disorders 55 blepharospasm 55 MELAS 55 daytime drowsiness 55 emotional lability 55 chronic neuropathic pain 55 clomipramine 55 CRVO 55 Cognitive dysfunction 55 neuroinflammatory 55 developmental abnormalities 55 dysmotility 55 mGluR2 NAM 55 claudication 55 neurological disorder affecting 55 choroidal neovascularization CNV 55 petit mal seizures 55 Barrett esophagus BE 55 osteoarthritis rheumatoid arthritis 55 liver histology 55 antidepressant efficacy 55 APOE ε4 55 sensory neuropathy 55 dysregulation 55 mild cognitive impairment 55 amnestic MCI 55 systemic corticosteroid 55 dyskinesias 55 reflux disease 55 congenital deficiency 55 comorbid conditions 55 neurological impairments 55 generalized tonic clonic seizures 55 cortical thinning 55 psychosocial variables 55 HIV HCV coinfected 55 neurocognitive disorder 55 vasomotor symptoms 55 Subarachnoid hemorrhage 55 akathisia 55 tonic clonic seizures 55 essential thrombocythemia 55 etiologic 55 morbidities 55 Primary IGFD 55 neuropathology 55 hepatic cirrhosis 55 hyperammonemia 55 psoriasis psoriatic arthritis 55 silent myocardial ischemia 55 variant angina 55 detrusor overactivity 55 AUDs 55 hyperexcitability 55 IUGR 55 post transplant lymphoproliferative 55 #q#.# deletion syndrome 55 uncontrolled seizures 55 prostate cancer CaP 55 depressive disorders 55 androgen deficiency 55 dementias 55 cryptogenic 55 Mild Cognitive Impairment 55 torsade de pointes 55 Oppositional Defiant Disorder 55 neuroendocrine 55 nasal polyposis 55 status epilepticus 55 TTR amyloidosis 55 syncope 55 psychiatric morbidity 55 kidney insufficiency 55 biochemical abnormalities 55 atherogenesis 55 EXJADE 55 rCBF 55 Eisenmenger syndrome 55 neuritic 55 occlusive disease 55 CLBP 55 hypopituitarism 55 thrombotic complications 55 ApoE gene 55 Genetic variants 55 unmeasured confounders 55 dysregulated 55 amyloid plaque formation 55 secondary hyperparathyroidism 55 carotid IMT 55 spastic diplegia 55 hypercholesterolemia 55 lactic acidosis 55 ataxias 55 experimentally induced 55 Dysregulation 55 spinocerebellar ataxia 55 Thrombotic thromboembolic complications 55 polyarticular 55 arrhythmogenic 54 metabolic dysfunction 54 endocrine abnormalities 54 Venous thromboembolism 54 primary aldosteronism 54 myoclonic seizures 54 primary Restless Legs 54 neuron degeneration 54 relapsing remitting 54 familial hypercholesterolemia FH 54 Ischemic 54 hypophosphatasia 54 Insulin resistance 54 constipation IBS C 54 cholinergic tone 54 Cerebellar 54 vascular inflammation 54 idiopathic generalized epilepsy 54 progressive neurologic 54 unknown etiology 54 disorders 54 Korsakoff 54 transaminase elevations 54 voiding dysfunction 54 glucocorticoid therapy 54 cognitive impairment associated 54 hematologic disorders 54 Irritable Bowel Syndrome IBS 54 myocardial infarction MI 54 onset seizures 54 hepatic dysfunction 54 chronicity 54 depressive symptoms 54 folate deficiency 54 cognitive 54 psychotic symptoms 54 PGTC seizures 54 LVNC 54 nonischemic 54 diabetic neuropathy 54 neurological 54 CNTNAP2 54 paroxysmal 54 levodopa induced 54 Vascular dementia 54 schizophrenia 54 hereditary hemochromatosis 54 debilitating neurodegenerative disorder 54 quetiapine Seroquel 54 lymphocyte activation 54 Myocardial infarction 54 demyelinating diseases 54 acute myelogenous leukemia AML 54 oculomotor 54 non affective psychosis 54 hypercalcaemia 54 allergic sensitization 54 hyperhomocysteinemia 54 hypovolemia 54 Myotonic dystrophy 54 susceptibility gene 54 posttraumatic 54 Sleep disturbances 54 postoperative atrial fibrillation 54 interstitial pneumonia 54 OAB symptoms 54 amyloid deposits 54 hyposmia 54 inherited neurological disorder 54 atherogenic dyslipidemia 54 neuroleptics 54 urate levels 54 motor neuropathy 54 cytopenia 54 frontal lobe dysfunction 54 prefrontal regions 54 Dr. Gozal 54 Angelman syndrome 54 prematurity ROP 54 paroxysmal AF 54 thyroiditis 54 AA Amyloidosis 54 dyskeratosis congenita 54 Atypical antipsychotics 54 cystic fibrosis chronic pancreatitis 54 akinetic mutism 54 galanin 54 Sjogren syndrome 54 inflammatory markers 54 cryptogenic stroke 54 retinal dysfunction 54 valvular heart disease 54 SIADH 54 idiopathic pulmonary fibrosis IPF 54 immunodeficiencies 54 vitamin B# deficiency 54 obliterative bronchiolitis 54 TEAEs 54 syncope fainting 54 idiopathic 54 hyperresponsiveness 54 pseudotumor cerebri 54 myotonic muscular dystrophy 54 affective disorders 54 spasticity 54 Neurofibromatosis type 54 thrombocytosis 54 pathophysiologic mechanisms 54 #q# deletion syndrome 54 neurodegenerative disorder characterized 54 HDL2 54 aortic atherosclerosis 54 neuroprotection 54 degenerative neurological disease 54 Obstructive sleep apnea OSA 54 interstitial fibrosis 54 Major depressive disorder 54 pathophysiology 54 elevated serum creatinine 54 androgenetic alopecia 54 SSc 54 Generalized anxiety disorder 54 irreversible blindness 54 neuropsychological impairment 54 decompensation 54 Chronic pancreatitis 54 presymptomatic 54 hypertension diabetes mellitus 54 familial ALS 54 aortic regurgitation 54 nocturnal enuresis 54 untreated OSA 54 subependymal giant cell 54 symptomatic intracranial 54 nephropathy 54 juvenile myoclonic epilepsy 54 GBA mutations 54 skeletal muscle weakness 54 myotonic dystrophy 54 Hurler syndrome 54 cardiovascular mortality 54 amnestic mild cognitive impairment 54 ragweed allergic 54 nonbacterial prostatitis 54 motor tics 54 vWD 54 chemobrain 54 clinically meaningful reductions 54 vitreous hemorrhage 54 cognitive domains 54 parathyroid 54 biochemical imbalance 54 sensorineural hearing loss 54 astrocytomas 54 neurotrophic 54 elevated triglycerides 54 Zollinger Ellison syndrome 54 habitual snoring 54 thyrotropin 54 typical antipsychotics 54 monogenic 54 arterial stiffness 54 irreversible neurological 54 enterocolitis 54 gastric carcinogenesis 54 myoglobinuria rhabdomyolysis 54 idiopathic intracranial hypertension 54 neoplasm 54 Lennox Gastaut Syndrome 54 hyperintense lesions 54 dyslipidaemia 54 cartilage degeneration 54 testicular tumors 54 Parkinson Disease PD 54 cognitively intact 54 hypoperfusion 54 cirrhosis liver failure 54 malabsorption 54 cardiac insufficiency 54 keloid scarring 54 diabetic retinopathy 54 metastatic malignant 54 bacterial prostatitis 54 imatinib resistance 54 Pathological gambling 54 Tourette Syndrome TS 54 thyroid carcinoma 54 cAMP signaling 54 neurogenic bladder 54 steatohepatitis 54 hypotonia 54 congenital anomalies 54 transaminase levels 54 hypercalciuria 54 vestibular dysfunction 54 chronic hepatitis cirrhosis 54 carcinoid tumors 54 debilitating autoimmune 54 premenstrual dysphoric disorder PMDD 54 Subgroup analysis 54 hemolytic anemia 54 PTLD 54 chronic periodontitis 54 cortical atrophy 54 cataract formation 54 recurrent seizures 54 Huntingtons disease 54 somnolence dizziness 54 lysosomal storage diseases 54 dopamine signaling 54 phonic tics 54 G6PD deficiency 54 preserved ejection fraction 54 neurological disorder characterized 54 VaD 54 precocious puberty 54 APOE gene 54 syncopal episodes 54 rare autosomal recessive 54 neovascularisation 54 Endothelial dysfunction 54 repolarization 54 liver fibrosis 54 hyperinsulinism 54 neurofibromatosis type 54 anosognosia 54 atherothrombotic 54 narcolepsy cataplexy 54 PsA 54 neurodegenerative diseases 54 gait disturbance 54 dysautonomia 54 perimenopausal women 54 familial hypercholesterolemia 54 VCFS 54 airway remodeling 54 CYT# potent vascular disrupting 54 neurofibrillary tangles 54 prolactin elevation 54 gastrointestinal mucositis 54 intravascular hemolysis 54 syndromes 54 Nicotine dependence 54 dyskinesia 54 Autistic Disorder 54 pain syndromes 54 CYP #A# 54 haematologic 54 erythematosus SLE 54 neuropathic 54 sub syndromal 54 muscle rigidity 54 prodromal 54 acute coronary syndromes 53 liver dysfunction 53 muscular dystrophies 53 pressure natriuresis 53 HPA axis 53 delayed CINV 53 hirsutism 53 bone marrow suppression 53 cardiovascular morbidity 53 alpha1 antitrypsin deficiency 53 glucose tolerance 53 intermittent hypoxia 53 hypocalcaemia 53 cerebral atrophy 53 NPHP 53 premorbid 53 neurodevelopmental impairment 53 Essential tremor 53 neuronal plasticity 53 pharmacological approaches 53 valvular disease 53 aetiology 53 vasodilatation 53 Alzheimer disease vascular dementia 53 androgen depletion 53 estrogen deficiency 53 retinal degeneration 53 Brodmann Area 53 antiphospholipid syndrome 53 inflammatory rheumatic 53 microvascular dysfunction 53 serotonin neurotransmission 53 unprovoked seizures 53 Parkinsonian symptoms 53 coronary calcification 53 embolic stroke 53 hyperkalemia 53 somatoform disorders 53 1 diabetes T1D 53 hyperthyroidism 53 elevated liver enzymes 53 COPD exacerbation 53 Essential Tremor 53 neuro developmental disorder 53 nonfatal MI 53 frontotemporal 53 tardive dyskinesia 53 enteroviral infection 53 Alzheimer Dementia 53 serum folate concentrations 53 airway responsiveness 53 predisposing factors 53 immunodeficiency 53 nephrotoxicity 53 pathophysiological 53 paroxysmal nocturnal hemoglobinuria 53 SHPT 53 glaucoma cataract 53 blindness paralysis 53 opioid naive 53 Lu AA# 53 Atopic dermatitis 53 bexarotene 53 cerebral perfusion 53 atherothrombotic disease 53 vesicoureteral reflux 53 riociguat 53 obstructive sleep apnea hypopnea 53 Opioid induced 53 venlafaxine Effexor 53 thyroid deficiency 53 term potentiation LTP 53 Conduct Disorder 53 diabetes mellitus T2DM 53 plasma kallikrein 53 VADT 53 airflow limitation 53 triiodothyronine 53 myocardial ischaemia 53 polycythemia vera essential thrombocythemia 53 bipolar illness 53 TMS Therapy 53 IL 1ß 53 elevated IOP 53 hyperbilirubinemia 53 colorectal adenomas 53 constipation predominant irritable bowel 53 fronto temporal dementia 53 neurocognition 53 Iron deficiency anemia 53 LRRK2 mutations 53 neurological complications 53 Leber Hereditary Optic Neuropathy 53 Compulsive hoarding 53 muscular degeneration 53 Tasimelteon 53 microglial activation 53 thyrotropin levels 53 neovascularization 53 dysmenorrhoea 53 cytomegalovirus infection 53 leukoencephalopathy PML 53 fibrotic 53 glucose homeostasis 53 comorbid 53 familial clustering 53 Social Anxiety Disorder 53 mitochondrial disorders 53 hepatic encephalopathy HE 53 lysosomal storage disorder 53 parasomnias 53 utero exposure 53 Tardive dyskinesia 53 sinus node dysfunction 53 major depressive disorder 53 radiculopathy 53 infantile spasms 53 thrombocytopenia neutropenia 53 Childhood Disorder 53 PCNSL 53 hypoxic ischemic encephalopathy 53 cholinergic 53 recurrent miscarriage 53 serotonin syndrome 53 levodopa therapy 53 AST ALT 53 lumbar disc disease 53 nociceptive pain 53 platelet activation 53 growth hormone secretion 53 Parkinsons Disease 53 de ath 53 anemias 53 polyp recurrence 53 dopaminergic cells 53 amblyopic 53 thromboembolic 53 Prostatitis 53 serum phosphate 53 decompensated cirrhosis 53 nonpharmacologic 53 ARMD 53 Leber congenital amaurosis 53 Cognitive Impairment 53 pharmacological interventions 53 Mood disorders 53 noradrenergic 53 hyperglycemia 53 kidney urologic 53 asymptomatic PAD 53 alzheimer disease 53 anterior uveitis 53 Cockayne syndrome 53 neurocognitive impairments 53 periprocedural MI 53 nonarteritic anterior ischemic optic 53 epithelial tumors 53 Retinopathy 53 depression irritability 53 vascular dysfunction 53 juvenile myelomonocytic leukemia 53 rFVIIa 53 thyroid hormone deficiency 53 vascular dementia 53 Becker muscular dystrophy 53 torsades de pointes 53 Restless legs 53 recurrent wheezing 53 atrial tachyarrhythmias 53 constipation OIC 53 involuntary movements 53 Polyneuropathy 53 somnolence fatigue 53 chronic renal disease 53 respiratory gastrointestinal 53 infarcts 53 open angle glaucoma 53 cortical activation 53 seizure disorders 53 antithrombotic therapy 53 neuronal degeneration 53 VMAT2 53 dilated cardiomyopathy DCM 53 gastrointestinal disturbances 53 ventricular dysfunction 53 diabetes insipidus 53 macular edema 53 fat malabsorption 53 pharmacologic intervention 53 clefting 53 Atherosclerotic 53 abdominal adiposity 53 Neurodegenerative diseases 53 leptin deficiency 53 inappropriate antidiuretic hormone SIADH 53 endocannabinoid signaling 53 eosinophilic esophagitis 53 behavioral disinhibition 53 disk herniation 53 TNF antagonist 53 DDP# 53 glutamatergic 53 Pseudobulbar affect PBA 53 recurrent glioblastoma multiforme 53 ABCB1 53 FSAD 53 pentoxifylline 53 upper airway obstruction 53 Irritable bowel syndrome 53 conventional antipsychotics 53 Hip dysplasia 53 poorer prognosis 53 metastatic bone 53 obstructive coronary 53 sudden sensorineural hearing 53 atherothrombosis 53 intracerebral haemorrhage 53 polycystic ovary syndrome PCOS 53 Borderline personality 53 Klinefelter syndrome 53 discoid lupus 53 esophageal reflux 53 neurological sequelae 53 allodynia 53 rufinamide 53 anticholinergic medications 53 mammary tumors 53 retinal dystrophies 53 renal kidney 53 hypothyroidism 53 pathogenetic mechanisms 53 crohn disease 53 prostate cancer PCa 53 citalopram 53 opioid induced 53 pathogenic mechanisms 53 thrombophilia 53 Non Alcoholic Steatohepatitis 53 Acute Coronary Syndromes ACS 53 polycystic ovary syndrome 53 systemic amyloidosis 53 inhibitory neurotransmitters 53 cerebral palsy mental retardation 53 acute mania 53 macrovascular events 53 JAK STAT signaling 53 complement inhibitor eculizumab 53 ovarian hormones 53 6R BH4 53 anticholinergic agents